Future directions in esophageal cancer therapy. - Wikidata - awgldk - TriplyDB

Future directions in esophageal cancer therapy.

Future directions in esophageal cancer therapy.

http://www.wikidata.org/entity/Q37747378

about

Nimotuzumab combined with concurrent chemoradiotherapy in Japanese patients with esophageal cancer: a phase I study.

P2860

Q49503130-0FA77897-EFB9-4AB3-80E1-8020BE561786

P2860

Future directions in esophageal cancer therapy.

http://www.wikidata.org/entity/Q37747378

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Future directions in esophageal cancer therapy.

@en

Future directions in esophageal cancer therapy.

@nl

type

label

Future directions in esophageal cancer therapy.

@en

Future directions in esophageal cancer therapy.

@nl

prefLabel

Future directions in esophageal cancer therapy.

@en

Future directions in esophageal cancer therapy.

@nl

P1433

Q37747378-C6D02B60-45B8-48C1-943E-575C3E61B599

P1476

Q37747378-4F67B1B6-D19E-4DE5-85AC-E5709C7DA1CD

P2093

Q37747378-24DB11D4-68C3-4D99-9B5C-F9AE1DC76D1D

Q37747378-4552472B-EECD-43F4-8600-39FF2A25E6ED

Q37747378-86520F92-2814-417D-B35B-51D1792ACE65

Q37747378-CDA3EE43-A280-4DEC-BC91-539087044DC3

P2860

Q37747378-0686D850-0CCD-472A-BD9A-0CEAAE959B25

Q37747378-111B9507-C129-40B9-875C-9B755A1C0D92

Q37747378-18318116-845F-4249-AF38-CBC501D11789

Q37747378-285FD435-B72B-45E3-BFE1-51DCC6B7401B

Q37747378-32D648BB-A3D5-4290-974E-AFEFB033E081

Q37747378-37C73703-C522-46A6-BEA7-25303E2BAAA9

Q37747378-39A35CDD-AF9C-487F-A982-39B0BEED4F0D

Q37747378-3BE56BFC-5AD6-4DF7-8936-ADA5D0942D51

Q37747378-441B949A-D09C-4585-8EA5-E369C63EE9A1

Q37747378-58042CE1-E019-40BE-989B-584CF246F17A

P304

Q37747378-8788ECAB-E176-4885-BD37-B472AA2F966C

P31

Q37747378-009E16F6-6F8C-4CC5-947E-16BEC26E17F3

P356

Q37747378-A5E97880-774D-4DAE-AADF-2D10E1DFEC27

P433

Q37747378-84FDD609-B68A-40C8-A9A0-67187E818D58

P478

Q37747378-DD530AD3-E210-4D12-9442-29118F99FBE3

P577

Q37747378-3EFF83CD-418D-4032-825B-89AA896950AE

P698

Q37747378-392F0EF4-5D58-4A3B-9BED-EE36A8F0AB56

P932

Q37747378-5C877963-A4D5-4A47-8AB7-BA90FC16B23F

P356

P1433

Annals of Cardiothoracic Surgery

P1476

Future directions in esophageal cancer therapy.

@en

P2093

Brandon Smaglo

http://www.w3.org/2001/XMLSchema#string

Henry Mok

http://www.w3.org/2001/XMLSchema#string

Ori Wald

http://www.w3.org/2001/XMLSchema#string

Shawn S Groth

http://www.w3.org/2001/XMLSchema#string

P2860

Nedaplatin: a cisplatin derivative in cancer chemotherapy

Endoscopic options for early stage esophageal cancer

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)

S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study.

Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients.

Outcomes after minimally invasive esophagectomy: review of over 1000 patients.

British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.

P304

159-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/ACS.2017.02.01

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28447005

http://www.w3.org/2001/XMLSchema#string

P932

5387153

http://www.w3.org/2001/XMLSchema#string